Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort Study.
Kin Wah FungFitsum BayeJoan Kapusnik-UnerClement J McDonaldPublished in: Drugs - real world outcomes (2021)
Medicare data can be utilized for post-marketing surveillance and monitoring of the proarrhythmic risk of QT-prolonging drugs in older adults.